Sutro Biopharma's market cap is currently $75.46M. The company's EPS TTM is $-0.14; its P/E ratio is ―; Sutro Biopharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
